UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Proof of concept of a new plasma complement Factor H from waste plasma fraction

Frontiers in immunology, 2024-06, Vol.15, p.1334151

2024

Volltextzugriff (PDF)

Therapeutic Solutions of Human Albumin – The Possible Effect of Process-Induced Molecular Alterations on Clinical Efficacy and Safety

Journal of pharmaceutical sciences, 2022-05, Vol.111 (5), p.1292-1308

2022

Volltextzugriff (PDF)

ADAMTS13 levels in a plasma-derived FVIII concentrate: A potential therapeutic option for patients with congenital thrombotic thrombocytopenic purpura

Thrombosis update, 2022-12, Vol.9, p.100120, Article 100120

2022

Volltextzugriff (PDF)

Biopharmaceutical Assessment of Mesh Aerosolised Plasminogen, a Step towards ARDS Treatment

Pharmaceutics, 2023-05, Vol.15 (6), p.1618

2023

Volltextzugriff (PDF)

Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics

Pharmaceuticals (Basel, Switzerland), 2020-11, Vol.13 (12), p.425

2020

Volltextzugriff (PDF)

Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

Bleeding, Thrombosis and Vascular Biology, 2022-05, Vol.1 (2)

2022

Volltextzugriff (PDF)

New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia

Communications biology, 2024-01, Vol.7 (1), p.140-140, Article 140

2024

Volltextzugriff (PDF)

New plasma protein C and protein S concentrate: A synergy for therapeutic purposes

Vox sanguinis, 2024-03, Vol.119 (3), p.193-202

2024

Volltextzugriff (PDF)

Post-translational modifications and antioxidant properties of different therapeutic human serum albumins

International journal of biological macromolecules, 2021-07, Vol.183, p.927-935

2021

Volltextzugriff (PDF)

Intra‐ and interassay variations of two thrombin generation methods

International journal of laboratory hematology, 2021-08, Vol.43 (4), p.O218-O220

2021

Volltextzugriff (PDF)

Purification and characterization of a new highly pure, double virus inactivated von Willebrand factor concentrate

Blood coagulation & fibrinolysis, 2018-01, Vol.29 (1), p.30-38

2018

Volltextzugriff (PDF)

Evaluation of prophylactic polyclonal anti‐D antibodies: Differences in Fc‐glycosylation in commercial products

Vox sanguinis, 2022-04, Vol.117 (4), p.624-625

2022

Volltextzugriff (PDF)

Characterization of a plasma‐derived double−viral‐inactivated factor VIII concentrate (antihaemophilic factor [human]): Focus on TTP treatment

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-05, Vol.27 (3), p.e409-e411

2021

Volltextzugriff (PDF)

Doxorubicin coupled to lactosaminated albumin: Effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats

European journal of pharmaceutical sciences, 2008-02, Vol.33 (2), p.191-198

2008

Volltextzugriff (PDF)

A multianalytical approach to investigate the effect of nanofiltration on plasma-derived factor IX clinical lots

Analytical biochemistry, 2018-02, Vol.542, p.1-10

2018

Volltextzugriff (PDF)

Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test

Blood coagulation & fibrinolysis, 2010-04, Vol.21 (3), p.221-228

2010

Volltextzugriff (PDF)

Characterization of factor VIII pharmaceutical preparations by means of MudPIT proteomic approach

Journal of pharmaceutical and biomedical analysis, 2010-09, Vol.53 (1), p.50-57

2010

Volltextzugriff (PDF)

Quality control of recovered plasma for fractionation: an extensive Italian study

Transfusion (Philadelphia, Pa.), 2008-07, Vol.48 (7), p.1459-1468

2008

Volltextzugriff (PDF)

A Novel Class of Highly Potent and Selective A1 Adenosine Antagonists: Structure−Affinity Profile of a Series of 1,8-Naphthyridine Derivatives

Journal of medicinal chemistry, 2000-07, Vol.43 (15), p.2814-2823

2000

Volltextzugriff (PDF)

A Novel Class of Highly Potent and Selective A 1 Adenosine Antagonists: Structure−Affinity Profile of a Series of 1,8-Naphthyridine Derivatives

Journal of medicinal chemistry, 2000-07, Vol.43 (15), p.2814-2823

2000

Volltextzugriff (PDF)

Condensation of substituted 2‐aminopyridine with β‐ketocarboxylic esters: 4 H ‐pyrido[1,2‐ a ]pyrimidin‐4‐ones and pyridin‐2‐ones

Journal of heterocyclic chemistry, 1999-09, Vol.36 (5), p.1123-1127

1999

Volltextzugriff (PDF)

Condensation of substituted 2-aminopyridine with β-ketocarboxylic esters: 4H-pyrido[1,2-a]pyrimidin-4-ones and pyridin-2-ones

Journal of heterocyclic chemistry, 1999-09, Vol.36 (5), p.1123-1127

1999

Volltextzugriff (PDF)

Lightweight structures and novel steel alloys resistant to impulsive loading

Mori, Lapo Filippo

2008

Volltextzugriff (PDF)

An unexpected result in the condensation of 2-amino-6-bromopyridine with ethyl 4-chloroacetoacetate: Four dihalo-substituted pyrido[1,2-a]pyrimidin-4-ones as reaction products

Journal of heterocyclic chemistry, 1999-07, Vol.36 (4), p.1065-1072

1999

Volltextzugriff (PDF)

Adamts13 Levels in a Plasma-Derived Fviii Concentrate: A Potential Therapeutic Option for Patients with Congenital Thrombotic Thrombocytopenic Purpura

SSRN Electronic Journal

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Proof of concept of a new plasma complement Factor H from waste plasma fraction

Therapeutic Solutions of Human Albumin – The Possible Effect of Process-Induced Molecular Alterations on Clinical Efficacy and Safety

ADAMTS13 levels in a plasma-derived FVIII concentrate: A potential therapeutic option for patients with congenital thrombotic thrombocytopenic purpura

Biopharmaceutical Assessment of Mesh Aerosolised Plasminogen, a Step towards ARDS Treatment

Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics

Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia

New plasma protein C and protein S concentrate: A synergy for therapeutic purposes

Post-translational modifications and antioxidant properties of different therapeutic human serum albumins

Intra‐ and interassay variations of two thrombin generation methods

Purification and characterization of a new highly pure, double virus inactivated von Willebrand factor concentrate

Evaluation of prophylactic polyclonal anti‐D antibodies: Differences in Fc‐glycosylation in commercial products

Characterization of a plasma‐derived double−viral‐inactivated factor VIII concentrate (antihaemophilic factor [human]): Focus on TTP treatment

Doxorubicin coupled to lactosaminated albumin: Effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats

A multianalytical approach to investigate the effect of nanofiltration on plasma-derived factor IX clinical lots

Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test

Characterization of factor VIII pharmaceutical preparations by means of MudPIT proteomic approach

Quality control of recovered plasma for fractionation: an extensive Italian study

A Novel Class of Highly Potent and Selective A1 Adenosine Antagonists: Structure−Affinity Profile of a Series of 1,8-Naphthyridine Derivatives

A Novel Class of Highly Potent and Selective A 1 Adenosine Antagonists: Structure−Affinity Profile of a Series of 1,8-Naphthyridine Derivatives

Condensation of substituted 2‐aminopyridine with β‐ketocarboxylic esters: 4 H ‐pyrido[1,2‐ a ]pyrimidin‐4‐ones and pyridin‐2‐ones

Condensation of substituted 2-aminopyridine with β-ketocarboxylic esters: 4H-pyrido[1,2-a]pyrimidin-4-ones and pyridin-2-ones

Lightweight structures and novel steel alloys resistant to impulsive loading

An unexpected result in the condensation of 2-amino-6-bromopyridine with ethyl 4-chloroacetoacetate: Four dihalo-substituted pyrido[1,2-a]pyrimidin-4-ones as reaction products

Adamts13 Levels in a Plasma-Derived Fviii Concentrate: A Potential Therapeutic Option for Patients with Congenital Thrombotic Thrombocytopenic Purpura

Suchergebnisse filtern